Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Fundstrat co-founder Tom Lee points to the ETH/BTC ratio as a sign of a potential leadership shift in crypto, suggest...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
A high-growth, small-cap name has tumbled after a rough period. This guide breaks down whether the dip creates a real...
First-quarter 2026 saw a record pace of home equity withdrawals as borrowers leaned on second liens and HELOCs rather...
Analysts publish an eyebrow-raising spacex’s $800 price target, implying a potential trillion-dollar leap in value an...
A prominent market analyst says Ethereum may be near a bottom, even as Vitalik Buterin sells ETH. Traders are weighin...
SoundHound posted revenue gains for the quarter, yet earnings slipped as acquisition-related costs weighed on results...
SpaceX’s impending IPO is driving the launch of leveraged ETFs designed to amplify bets on the rocket company, offeri...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...